Abstracts

Antiretroviral Therapy Reduces Intrahepatic Hepatitis C in HIV-1/HCV Coinfection

HIV-1 worsens hepatitis C virus (HCV) replication in co-infected patients, and we and others have recently reported that antiretroviral therapy (ART) initiation reduces plasma HCV RNA levels (Sherman, Sci Trans Med, 2014; Balagopal, Hepatology, 2014). We now test the hypothesis that HIV-1 control with ART decreases intrahepatic HCV replication. We obtained paired plasma samples and…

Broadly Neutralizing Antibodies Avert HCV ReInfection or Subsequent Chronic Infection

Understanding of protective immunity against hepatitis C virus (HCV) chronic infection is needed for designing an effective vaccine. Development of a broad neutralizing antibody response against the HCV E1E2 glycoproteins early in infection has been associated with clearance of infection. However, little is known about the characteristics of protective antibodies. Therefore, we analyzed the antibody repertoire…

Ledipasvir/Sofosbuvir for 6 Weeks in HIV-Infected Patients With Acute HCV Infection

There is no currently approved treatment for acute HCV infection. Guidelines recommend 24 weeks of therapy with interferon (IFN) and ribavirin in HIV coinfected individuals who are diagnosed with acute HCV. Shorter duration therapy with all-oral agents may offer a better-tolerated more efficacious  alternative. Here we evaluated the safety, tolerability and efficacy of ledipasvir (LDV)/sofosbuvir…

HIV in Fishing Communities: Prevalence, Incidence, Risk Factors, and Interventions

As the world coalesces around achieving WHO’s 90-90-90 targets, initial steps are focused on finding and shutting down sources of new infections. We sought to describe the burden, risk factors and potential prevention interventions for HIV infections in fishing communities. This largely involves syntheses of published findings as well as findings from recent studies in the…

HIV and Migrants

Migrants have been long identified as one of the populations with highest vulnerability to HIV infection and its consequences.  Migrants encompass heterogeneous groups of persons with different migration drivers – economic, social, political, cultural and environmental – as well as with distinct risk-contexts for HIV infection. Some migrant groups have a disproportionate burden of HIV…